JNPSX
Price
$25.79
Change
-$0.32 (-1.23%)
Updated
Sep 20 closing price
WCMJX
Price
$13.83
Change
-$0.14 (-1.00%)
Updated
Sep 20 closing price
Ad is loading...

JNPSX vs WCMJX

Header iconJNPSX vs WCMJX Comparison
Open Charts JNPSX vs WCMJXBanner chart's image
Janus Henderson Small Cap Value D
Price$25.79
Change-$0.32 (-1.23%)
VolumeN/A
CapitalizationN/A
WCM SMID Quality Val Fd Investor
Price$13.83
Change-$0.14 (-1.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JNPSX vs WCMJX Comparison Chart
Loading...
VS
JNPSX vs. WCMJX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNPSX is a Buy and WCMJX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JNPSX has more cash in the bank: 1.58B vs. WCMJX (77.1M). JNPSX pays higher dividends than WCMJX: JNPSX (0.81) vs WCMJX (0.00). JNPSX was incepted earlier than WCMJX: JNPSX (37 years) vs WCMJX (5 years). JNPSX is a more actively managed with annual turnover of: 44.00 vs. WCMJX (22.00). WCMJX has a lower initial minimum investment than JNPSX: WCMJX (1000) vs JNPSX (2500). WCMJX annual gain was more profitable for investors over the last year : 22.21 vs. JNPSX (20.92).
JNPSXWCMJXJNPSX / WCMJX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years5 years-
Gain YTD11.34313.41185%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B77.1M2,053%
Annual Yield % from dividends0.810.00-
Returns for 1 year20.9222.2194%
Returns for 3 years13.8619.4471%
Returns for 5 years25.88N/A-
Returns for 10 years7.92N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KUKE0.720.03
+3.83%
Kuke Music Holding Limited
HRB64.460.78
+1.22%
H&R Block
BKNG4063.9146.40
+1.15%
Booking Holdings
FARO18.06-0.15
-0.82%
FARO Technologies
VRDN22.30-0.20
-0.89%
Viridian Therapeutics